– Reuters
Why These 5 Tesla Analysts Have Mixed Views On Q3: ‘We Were Prepared For An Earnings Miss’
Tesla Inc (NASDAQ: TSLA) reported record revenue, operating margins and free cash flow in the third quarter.
Related Posts
What’s Going On With Revolution Medicines Stock?
Revolution Medicines announced the publication of a peer-reviewed research paper in "Cancer Discovery" detailing the discovery and preclinical to clinical translation for RMC-6236 on Monday. The company also announced the publication of two peer-reviewed research papers in "Nature" Tuesday. The first paper highlights the discovery and preclinical characterization of RMC-7977, and the second paper highlights the systematic evaluation of RMC-7977 in a wide range of preclinical models of PDAC.
Why Gilead Sciences Stock Is Falling Today
Gilead Sciences Inc (NASDAQ: GILD) reported Q1 FY23 sales decreased 4% Y/Y to $6.35 billion, slightly above the consensus of $6.33 billion, due to lower Veklury (remdesivir) sales, partially offset by increased
Amid Telsa, BYD Competition, Volkswagen Slashes ID.4 Electric SUV Prices In China To $20K
German automaker, Volkswagen AG (OTC:VWAGY), has significantly reduced the prices of its ID.4 electric SUV in China, now starting at $20,000, according…